EUVIMEDEUVIMED entdecken
Open Access

miRNA-loaded biomimetic nanoparticles orchestrate gut microbe to ameliorate inflammatory bowel disease

Wenjuan Liu iD, Jinlong Yang iD, Zibo Wei, Weiwen Kong, Zirong Dong, Yuning Wei, Jie Zhuang, Jianping Qi iD

Science Advances · 21.11.2025 · 11 (47)

DOI: 10.1126/sciadv.adw5984 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Science Advances, erschienen am 21.11.2025. Verfasst von Wenjuan Liu und 7 weiteren Autor:innen. Beteiligte Einrichtung: School of Pharmaceutical Sciences, Fudan University, Key Laboratory of Smart Drug Delivery, Ministry of Education, State Key Laboratory of Advanced D…. Hauptthemen laut MEDLINE: MicroRNAs, Nanoparticles, Inflammatory Bowel Diseases, Gastrointestinal Microbiome. Die Arbeit wurde bisher 20-mal zitiert (Crossref) und nennt 64 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar. Gefördert von: National Natural Science Foundation of China.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Modulation of gut microbiota has emerged as a promising therapeutic strategy for inflammatory bowel disease (IBD). However, current interventions such as probiotics and fecal microbiota transplantation remain limited by insufficient safety and efficacy. To address this, we engineered commensal Lactobacillus rhamnosus (LGG) using miRNA-loaded biomimetic nanoparticles to enhance its proliferation and indole-3-carboxaldehyde production. By functionalizing bacterial extracellular vesicles (BEVs) derived from LGG with lipid nanoparticles (LNPs), we developed BEV-LNPs that exhibited enhanced targeting efficiency toward LGG compared to Escherichia coli . In vitro and in vivo studies demonstrated that BEV-LNPs showed superior stability in simulated physiological fluids and gastrointestinal environments compared to conventional LNPs. When combined with 5-aminosalicylic acid, the BEV-LNP formulation notably improved outcomes in acute and chronic colitis models, reducing inflammation, restoring epithelial barrier integrity, and promoting microbial balance. This study presents an effective strategy for colitis treatment by leveraging miRNA-loaded nanoparticles.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

MicroRNAsNanoparticlesInflammatory Bowel DiseasesGastrointestinal MicrobiomeBiomimetic MaterialsAnimalsMiceLacticaseibacillus rhamnosusExtracellular VesiclesDisease Models, AnimalHumansColitisBiomimeticsProbiotics

Substanzen

MicroRNAs

Autor:innen und Institutionen

  • School of Pharmaceutical Sciences, Fudan University, Key Laboratory of Smart Drug Delivery, Ministry of Education, State Key Laboratory of Advanced Drug Formulations for Overcoming Delivery Barriers, Shanghai 201203, Ch…
  • Shanghai Skin Disease Hospital, School of Medicine, Tongji University, Shanghai 200443, China.
  • School of Pharmacy, Shanghai University of Medicine and Health Sciences, Shanghai 201318, China.

ORCID-Profile: Wenjuan Liu, Jinlong Yang, Jianping Qi

Förderung

  • National Natural Science Foundation of China

Zitieren

APA

Liu, W., Yang, J., Wei, Z., Kong, W., Dong, Z., Wei, Y., Zhuang, J., & Qi, J. (2025). miRNA-loaded biomimetic nanoparticles orchestrate gut microbe to ameliorate inflammatory bowel disease. Science Advances, 11(47). https://doi.org/10.1126/sciadv.adw5984

Vancouver

Liu W, Yang J, Wei Z, Kong W, Dong Z, Wei Y, et al. miRNA-loaded biomimetic nanoparticles orchestrate gut microbe to ameliorate inflammatory bowel disease. Science Advances. 2025;11(47). doi:10.1126/sciadv.adw5984

BibTeX
@article{Liu2025,
  author = {Liu, Wenjuan and Yang, Jinlong and Wei, Zibo and Kong, Weiwen and Dong, Zirong and Wei, Yuning and Zhuang, Jie and Qi, Jianping},
  title = {miRNA-loaded biomimetic nanoparticles orchestrate gut microbe to ameliorate inflammatory bowel disease},
  journal = {Science Advances},
  year = {2025},
  volume = {11},
  number = {47},
  doi = {10.1126/sciadv.adw5984}
}
Kostenlos starten →